(19)
(11) EP 2 592 084 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.08.2014 Bulletin 2014/35

(45) Mention of the grant of the patent:
09.07.2014 Bulletin 2014/28

(21) Application number: 13154660.8

(22) Date of filing: 13.08.2008
(51) International Patent Classification (IPC): 
C07D 493/04(2006.01)

(54)

Process for producing pyripyropene derivatives and intermediates for the production thereof.

Verfahren zur Herstellung von Pyripyropenderivate und Zwischenstoffe zur Herstellung davon

Procédé de production de dérivés de pyripyropène et intermédiaires pour leur production

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 13.08.2007 JP 2007210804

(43) Date of publication of application:
15.05.2013 Bulletin 2013/20

(62) Application number of the earlier application in accordance with Art. 76 EPC:
08827512.8 / 2186815

(73) Proprietor: BASF SE
67056 Ludwigshafen (DE)

(72) Inventors:
  • Goto, Kimihiko
    Yokohama-shi, Kanagawa 222-8567 (JP)
  • Yamamoto, Kazumi
    Yokohama-shi, Kanagawa 222-8567 (JP)
  • Sakai, Masayo
    Yokohama-shi, Kanagawa 222-8567 (JP)
  • Mitomi, Masaaki
    Yokohama-shi, Kanagawa 222-8567 (JP)
  • Takashi, Ando
    Yokohama-shi, Kanagawa 222-8567 (JP)

(74) Representative: Regimbeau 
20, rue de Chazelles
75847 Paris Cedex 17
75847 Paris Cedex 17 (FR)


(56) References cited: : 
EP-A1- 1 889 540
   
  • RIKA OBATA ET AL: "Chemical modification and structure-activity relationships of pyripyropenes; potent, bioavailable inhibitor of acyl-CoA: cholesterol O-acyltransferase(ACAT)", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 5, no. 22, 1995, pages 2683-2688, XP004135214, ISSN: 0960-894X, DOI: 10.1016/0960-894X(95)00451-X
  • RIKA OBATA ET AL: "Chemical modification and structure-activity relationships of pyripyropenes. 2. 1, 11-Cyclic analogs", THE JOURNAL OF ANTIBIOTICS, vol. 49, no. 11, 1996, pages 1149-1156, XP008130150, ISSN: 0021-8820
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).